Project
Inflammatory response time course, HUVEC (Wada et al., 2009)
Navigation
Downloads
Results for RHOXF1
Z-value: 1.72
Motif logo
Transcription factors associated with RHOXF1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
RHOXF1
|
ENSG00000101883.4 | Rhox homeobox family member 1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| RHOXF1 | hg19_v2_chrX_-_119249819_119249847 | 0.66 | 3.5e-04 | Click! |
Activity profile of RHOXF1 motif
Sorted Z-values of RHOXF1 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr9_-_123676827 | 10.56 |
ENST00000546084.1
|
TRAF1
|
TNF receptor-associated factor 1 |
| chr8_+_54764346 | 10.55 |
ENST00000297313.3
ENST00000344277.6 |
RGS20
|
regulator of G-protein signaling 20 |
| chr4_+_74606223 | 7.70 |
ENST00000307407.3
ENST00000401931.1 |
IL8
|
interleukin 8 |
| chr6_-_32820529 | 7.65 |
ENST00000425148.2
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) |
| chr1_-_173020056 | 7.30 |
ENST00000239468.2
ENST00000404377.3 |
TNFSF18
|
tumor necrosis factor (ligand) superfamily, member 18 |
| chr1_-_184943610 | 6.51 |
ENST00000367511.3
|
FAM129A
|
family with sequence similarity 129, member A |
| chr11_-_102651343 | 6.43 |
ENST00000279441.4
ENST00000539681.1 |
MMP10
|
matrix metallopeptidase 10 (stromelysin 2) |
| chr1_+_169079823 | 6.32 |
ENST00000367813.3
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide |
| chr7_+_55177416 | 5.83 |
ENST00000450046.1
ENST00000454757.2 |
EGFR
|
epidermal growth factor receptor |
| chr1_-_153521714 | 5.49 |
ENST00000368713.3
|
S100A3
|
S100 calcium binding protein A3 |
| chr15_-_80263506 | 4.90 |
ENST00000335661.6
|
BCL2A1
|
BCL2-related protein A1 |
| chr1_-_150738261 | 4.86 |
ENST00000448301.2
ENST00000368985.3 |
CTSS
|
cathepsin S |
| chr15_+_67458357 | 4.78 |
ENST00000537194.2
|
SMAD3
|
SMAD family member 3 |
| chr16_-_67970990 | 4.74 |
ENST00000358514.4
|
PSMB10
|
proteasome (prosome, macropain) subunit, beta type, 10 |
| chr15_+_67418047 | 4.65 |
ENST00000540846.2
|
SMAD3
|
SMAD family member 3 |
| chr6_-_37225391 | 4.38 |
ENST00000356757.2
|
TMEM217
|
transmembrane protein 217 |
| chr6_-_37225367 | 4.28 |
ENST00000336655.2
|
TMEM217
|
transmembrane protein 217 |
| chr2_+_102721023 | 4.21 |
ENST00000409589.1
ENST00000409329.1 |
IL1R1
|
interleukin 1 receptor, type I |
| chr6_+_127898312 | 3.87 |
ENST00000329722.7
|
C6orf58
|
chromosome 6 open reading frame 58 |
| chr12_+_113344755 | 3.83 |
ENST00000550883.1
|
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
| chr10_-_101380121 | 3.70 |
ENST00000370495.4
|
SLC25A28
|
solute carrier family 25 (mitochondrial iron transporter), member 28 |
| chr11_+_20044096 | 3.54 |
ENST00000533917.1
|
NAV2
|
neuron navigator 2 |
| chr7_-_22259845 | 3.38 |
ENST00000420196.1
|
RAPGEF5
|
Rap guanine nucleotide exchange factor (GEF) 5 |
| chr6_-_32821599 | 3.34 |
ENST00000354258.4
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) |
| chr2_-_202563414 | 3.20 |
ENST00000409474.3
ENST00000315506.7 ENST00000359962.5 |
MPP4
|
membrane protein, palmitoylated 4 (MAGUK p55 subfamily member 4) |
| chr9_-_38069208 | 3.10 |
ENST00000377707.3
ENST00000377700.4 |
SHB
|
Src homology 2 domain containing adaptor protein B |
| chr16_+_56598961 | 3.08 |
ENST00000219162.3
|
MT4
|
metallothionein 4 |
| chr12_+_113344811 | 3.02 |
ENST00000551241.1
ENST00000553185.1 ENST00000550689.1 |
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
| chr8_-_125577940 | 3.01 |
ENST00000519168.1
ENST00000395508.2 |
MTSS1
|
metastasis suppressor 1 |
| chr12_+_113354341 | 2.95 |
ENST00000553152.1
|
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
| chr17_+_74381343 | 2.87 |
ENST00000392496.3
|
SPHK1
|
sphingosine kinase 1 |
| chr11_+_35211511 | 2.81 |
ENST00000524922.1
|
CD44
|
CD44 molecule (Indian blood group) |
| chr4_-_681114 | 2.79 |
ENST00000503156.1
|
MFSD7
|
major facilitator superfamily domain containing 7 |
| chr2_+_201997676 | 2.77 |
ENST00000462763.1
ENST00000479953.2 |
CFLAR
|
CASP8 and FADD-like apoptosis regulator |
| chr3_+_133293278 | 2.77 |
ENST00000508481.1
ENST00000420115.2 ENST00000504867.1 ENST00000507408.1 ENST00000511392.1 ENST00000515421.1 |
CDV3
|
CDV3 homolog (mouse) |
| chr1_+_212738676 | 2.77 |
ENST00000366981.4
ENST00000366987.2 |
ATF3
|
activating transcription factor 3 |
| chr3_-_189840223 | 2.73 |
ENST00000427335.2
|
LEPREL1
|
leprecan-like 1 |
| chr6_+_31553978 | 2.72 |
ENST00000376096.1
ENST00000376099.1 ENST00000376110.3 |
LST1
|
leukocyte specific transcript 1 |
| chr5_+_35856951 | 2.68 |
ENST00000303115.3
ENST00000343305.4 ENST00000506850.1 ENST00000511982.1 |
IL7R
|
interleukin 7 receptor |
| chr14_+_51955831 | 2.62 |
ENST00000356218.4
|
FRMD6
|
FERM domain containing 6 |
| chr12_-_89919965 | 2.58 |
ENST00000548729.1
|
POC1B-GALNT4
|
POC1B-GALNT4 readthrough |
| chr5_-_150460914 | 2.57 |
ENST00000389378.2
|
TNIP1
|
TNFAIP3 interacting protein 1 |
| chr2_+_201997595 | 2.55 |
ENST00000470178.2
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator |
| chr2_+_69201705 | 2.53 |
ENST00000377938.2
|
GKN1
|
gastrokine 1 |
| chr2_-_231090344 | 2.52 |
ENST00000540870.1
ENST00000416610.1 |
SP110
|
SP110 nuclear body protein |
| chr16_-_50715196 | 2.50 |
ENST00000423026.2
|
SNX20
|
sorting nexin 20 |
| chr6_+_31553901 | 2.46 |
ENST00000418507.2
ENST00000438075.2 ENST00000376100.3 ENST00000376111.4 |
LST1
|
leukocyte specific transcript 1 |
| chr6_-_11779840 | 2.39 |
ENST00000506810.1
|
ADTRP
|
androgen-dependent TFPI-regulating protein |
| chr17_+_77018896 | 2.37 |
ENST00000578229.1
|
C1QTNF1
|
C1q and tumor necrosis factor related protein 1 |
| chr16_-_65155979 | 2.33 |
ENST00000562325.1
ENST00000268603.4 |
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast) |
| chr2_+_201997492 | 2.31 |
ENST00000494258.1
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator |
| chr5_+_76114758 | 2.29 |
ENST00000514165.1
ENST00000296677.4 |
F2RL1
|
coagulation factor II (thrombin) receptor-like 1 |
| chr12_-_57522813 | 2.27 |
ENST00000556155.1
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced |
| chr1_-_205325850 | 2.27 |
ENST00000537168.1
|
KLHDC8A
|
kelch domain containing 8A |
| chr22_+_30821732 | 2.24 |
ENST00000355143.4
|
MTFP1
|
mitochondrial fission process 1 |
| chr11_+_35201826 | 2.23 |
ENST00000531873.1
|
CD44
|
CD44 molecule (Indian blood group) |
| chr16_-_65155833 | 2.23 |
ENST00000566827.1
ENST00000394156.3 ENST00000562998.1 |
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast) |
| chr10_+_104154229 | 2.22 |
ENST00000428099.1
ENST00000369966.3 |
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) |
| chr12_-_89920030 | 2.22 |
ENST00000413530.1
ENST00000547474.1 |
GALNT4
POC1B-GALNT4
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 4 (GalNAc-T4) POC1B-GALNT4 readthrough |
| chr6_-_11779014 | 2.21 |
ENST00000229583.5
|
ADTRP
|
androgen-dependent TFPI-regulating protein |
| chr7_-_122339162 | 2.21 |
ENST00000340112.2
|
RNF133
|
ring finger protein 133 |
| chr19_+_10397648 | 2.17 |
ENST00000340992.4
ENST00000393717.2 |
ICAM4
|
intercellular adhesion molecule 4 (Landsteiner-Wiener blood group) |
| chr16_-_72128270 | 2.17 |
ENST00000426362.2
|
TXNL4B
|
thioredoxin-like 4B |
| chr19_+_10397621 | 2.15 |
ENST00000380770.3
|
ICAM4
|
intercellular adhesion molecule 4 (Landsteiner-Wiener blood group) |
| chr20_+_6748311 | 2.15 |
ENST00000378827.4
|
BMP2
|
bone morphogenetic protein 2 |
| chr4_-_69536346 | 2.14 |
ENST00000338206.5
|
UGT2B15
|
UDP glucuronosyltransferase 2 family, polypeptide B15 |
| chr7_-_139763521 | 2.12 |
ENST00000263549.3
|
PARP12
|
poly (ADP-ribose) polymerase family, member 12 |
| chr18_-_53804580 | 2.04 |
ENST00000590484.1
ENST00000589293.1 ENST00000587904.1 ENST00000591974.1 |
RP11-456O19.4
|
RP11-456O19.4 |
| chr1_+_26759295 | 2.02 |
ENST00000430232.1
|
DHDDS
|
dehydrodolichyl diphosphate synthase |
| chr1_-_150208320 | 1.97 |
ENST00000534220.1
|
ANP32E
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member E |
| chr15_+_62359175 | 1.97 |
ENST00000355522.5
|
C2CD4A
|
C2 calcium-dependent domain containing 4A |
| chr11_-_117748138 | 1.97 |
ENST00000527717.1
|
FXYD6
|
FXYD domain containing ion transport regulator 6 |
| chr5_-_16936340 | 1.96 |
ENST00000507288.1
ENST00000513610.1 |
MYO10
|
myosin X |
| chr11_+_35211429 | 1.95 |
ENST00000525688.1
ENST00000278385.6 ENST00000533222.1 |
CD44
|
CD44 molecule (Indian blood group) |
| chr15_-_55541227 | 1.93 |
ENST00000566877.1
|
RAB27A
|
RAB27A, member RAS oncogene family |
| chr22_+_21996549 | 1.92 |
ENST00000248958.4
|
SDF2L1
|
stromal cell-derived factor 2-like 1 |
| chr1_+_165796753 | 1.92 |
ENST00000367879.4
|
UCK2
|
uridine-cytidine kinase 2 |
| chr18_+_21693306 | 1.92 |
ENST00000540918.2
|
TTC39C
|
tetratricopeptide repeat domain 39C |
| chr11_+_35198243 | 1.92 |
ENST00000528455.1
|
CD44
|
CD44 molecule (Indian blood group) |
| chr22_+_21133469 | 1.91 |
ENST00000406799.1
|
SERPIND1
|
serpin peptidase inhibitor, clade D (heparin cofactor), member 1 |
| chr2_-_202562774 | 1.90 |
ENST00000396886.3
ENST00000409143.1 |
MPP4
|
membrane protein, palmitoylated 4 (MAGUK p55 subfamily member 4) |
| chr15_+_74287118 | 1.89 |
ENST00000563500.1
|
PML
|
promyelocytic leukemia |
| chr1_+_169077172 | 1.89 |
ENST00000499679.3
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide |
| chr15_+_74287009 | 1.89 |
ENST00000395135.3
|
PML
|
promyelocytic leukemia |
| chr10_+_72575643 | 1.87 |
ENST00000373202.3
|
SGPL1
|
sphingosine-1-phosphate lyase 1 |
| chr12_+_7941989 | 1.87 |
ENST00000229307.4
|
NANOG
|
Nanog homeobox |
| chr6_+_31554826 | 1.85 |
ENST00000376089.2
ENST00000396112.2 |
LST1
|
leukocyte specific transcript 1 |
| chr1_+_159409512 | 1.85 |
ENST00000423932.3
|
OR10J1
|
olfactory receptor, family 10, subfamily J, member 1 |
| chr5_+_54320078 | 1.83 |
ENST00000231009.2
|
GZMK
|
granzyme K (granzyme 3; tryptase II) |
| chr22_-_50964849 | 1.83 |
ENST00000543927.1
ENST00000423348.1 |
SCO2
|
SCO2 cytochrome c oxidase assembly protein |
| chr5_-_54830871 | 1.83 |
ENST00000307259.8
|
PPAP2A
|
phosphatidic acid phosphatase type 2A |
| chr15_-_55563072 | 1.83 |
ENST00000567380.1
ENST00000565972.1 ENST00000569493.1 |
RAB27A
|
RAB27A, member RAS oncogene family |
| chr3_+_111393659 | 1.81 |
ENST00000477665.1
|
PLCXD2
|
phosphatidylinositol-specific phospholipase C, X domain containing 2 |
| chr15_-_55562479 | 1.81 |
ENST00000564609.1
|
RAB27A
|
RAB27A, member RAS oncogene family |
| chr14_-_24615805 | 1.80 |
ENST00000560410.1
|
PSME2
|
proteasome (prosome, macropain) activator subunit 2 (PA28 beta) |
| chr17_-_40264692 | 1.79 |
ENST00000591220.1
ENST00000251642.3 |
DHX58
|
DEXH (Asp-Glu-X-His) box polypeptide 58 |
| chr10_+_114135004 | 1.78 |
ENST00000393081.1
|
ACSL5
|
acyl-CoA synthetase long-chain family member 5 |
| chr7_-_23053693 | 1.76 |
ENST00000409763.1
ENST00000409923.1 |
FAM126A
|
family with sequence similarity 126, member A |
| chr1_+_165797024 | 1.74 |
ENST00000372212.4
|
UCK2
|
uridine-cytidine kinase 2 |
| chr11_+_35198118 | 1.72 |
ENST00000525211.1
ENST00000526000.1 ENST00000279452.6 ENST00000527889.1 |
CD44
|
CD44 molecule (Indian blood group) |
| chr15_-_55562582 | 1.71 |
ENST00000396307.2
|
RAB27A
|
RAB27A, member RAS oncogene family |
| chr3_-_58613323 | 1.71 |
ENST00000474531.1
ENST00000465970.1 |
FAM107A
|
family with sequence similarity 107, member A |
| chr14_-_58894332 | 1.71 |
ENST00000395159.2
|
TIMM9
|
translocase of inner mitochondrial membrane 9 homolog (yeast) |
| chr16_+_56691838 | 1.70 |
ENST00000394501.2
|
MT1F
|
metallothionein 1F |
| chr15_+_74287035 | 1.68 |
ENST00000395132.2
ENST00000268059.6 ENST00000354026.6 ENST00000268058.3 ENST00000565898.1 ENST00000569477.1 ENST00000569965.1 ENST00000567543.1 ENST00000436891.3 ENST00000435786.2 ENST00000564428.1 ENST00000359928.4 |
PML
|
promyelocytic leukemia |
| chr1_+_113217043 | 1.68 |
ENST00000413052.2
|
MOV10
|
Mov10, Moloney leukemia virus 10, homolog (mouse) |
| chr16_+_56691911 | 1.68 |
ENST00000568475.1
|
MT1F
|
metallothionein 1F |
| chr7_-_38370536 | 1.67 |
ENST00000390343.2
|
TRGV8
|
T cell receptor gamma variable 8 |
| chr22_-_17602143 | 1.67 |
ENST00000331437.3
|
CECR6
|
cat eye syndrome chromosome region, candidate 6 |
| chr22_+_30477000 | 1.65 |
ENST00000403975.1
|
HORMAD2
|
HORMA domain containing 2 |
| chr9_+_103189405 | 1.65 |
ENST00000395067.2
|
MSANTD3
|
Myb/SANT-like DNA-binding domain containing 3 |
| chr19_-_7562334 | 1.64 |
ENST00000593942.1
|
PEX11G
|
peroxisomal biogenesis factor 11 gamma |
| chrX_+_153409678 | 1.62 |
ENST00000369951.4
|
OPN1LW
|
opsin 1 (cone pigments), long-wave-sensitive |
| chr7_+_134331550 | 1.61 |
ENST00000344924.3
ENST00000418040.1 ENST00000393132.2 |
BPGM
|
2,3-bisphosphoglycerate mutase |
| chr3_+_14716606 | 1.60 |
ENST00000253697.3
ENST00000435614.1 ENST00000412910.1 |
C3orf20
|
chromosome 3 open reading frame 20 |
| chr6_-_87804815 | 1.60 |
ENST00000369582.2
|
CGA
|
glycoprotein hormones, alpha polypeptide |
| chr3_-_16524357 | 1.58 |
ENST00000432519.1
|
RFTN1
|
raftlin, lipid raft linker 1 |
| chr1_-_201096312 | 1.58 |
ENST00000449188.2
|
ASCL5
|
achaete-scute family bHLH transcription factor 5 |
| chr1_+_113217073 | 1.58 |
ENST00000369645.1
|
MOV10
|
Mov10, Moloney leukemia virus 10, homolog (mouse) |
| chr2_-_175711133 | 1.57 |
ENST00000409597.1
ENST00000413882.1 |
CHN1
|
chimerin 1 |
| chr22_+_30821784 | 1.55 |
ENST00000407550.3
|
MTFP1
|
mitochondrial fission process 1 |
| chr5_+_67588391 | 1.54 |
ENST00000523872.1
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
| chr17_+_46985731 | 1.52 |
ENST00000360943.5
|
UBE2Z
|
ubiquitin-conjugating enzyme E2Z |
| chrX_+_69488174 | 1.51 |
ENST00000480877.2
ENST00000307959.8 |
ARR3
|
arrestin 3, retinal (X-arrestin) |
| chr22_-_17602200 | 1.49 |
ENST00000399875.1
|
CECR6
|
cat eye syndrome chromosome region, candidate 6 |
| chr16_+_56691606 | 1.49 |
ENST00000334350.6
|
MT1F
|
metallothionein 1F |
| chr1_-_21606013 | 1.49 |
ENST00000357071.4
|
ECE1
|
endothelin converting enzyme 1 |
| chr8_-_8751068 | 1.48 |
ENST00000276282.6
|
MFHAS1
|
malignant fibrous histiocytoma amplified sequence 1 |
| chrX_-_77225135 | 1.46 |
ENST00000458128.1
|
PGAM4
|
phosphoglycerate mutase family member 4 |
| chr7_+_134551583 | 1.43 |
ENST00000435928.1
|
CALD1
|
caldesmon 1 |
| chr1_-_207226313 | 1.43 |
ENST00000367084.1
|
YOD1
|
YOD1 deubiquitinase |
| chr3_+_111393501 | 1.43 |
ENST00000393934.3
|
PLCXD2
|
phosphatidylinositol-specific phospholipase C, X domain containing 2 |
| chr17_-_39324424 | 1.42 |
ENST00000391356.2
|
KRTAP4-3
|
keratin associated protein 4-3 |
| chr6_-_31926208 | 1.42 |
ENST00000454913.1
ENST00000436289.2 |
NELFE
|
negative elongation factor complex member E |
| chr4_+_146560245 | 1.42 |
ENST00000541599.1
|
MMAA
|
methylmalonic aciduria (cobalamin deficiency) cblA type |
| chr12_+_26126681 | 1.41 |
ENST00000542865.1
|
RASSF8
|
Ras association (RalGDS/AF-6) domain family (N-terminal) member 8 |
| chr22_-_45608324 | 1.41 |
ENST00000496226.1
ENST00000251993.7 |
KIAA0930
|
KIAA0930 |
| chr2_+_232063436 | 1.40 |
ENST00000440107.1
|
ARMC9
|
armadillo repeat containing 9 |
| chr11_-_60929074 | 1.39 |
ENST00000301765.5
|
VPS37C
|
vacuolar protein sorting 37 homolog C (S. cerevisiae) |
| chr2_-_197226875 | 1.38 |
ENST00000409111.1
|
HECW2
|
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2 |
| chr11_+_5710919 | 1.38 |
ENST00000379965.3
ENST00000425490.1 |
TRIM22
|
tripartite motif containing 22 |
| chr21_+_25801041 | 1.37 |
ENST00000453784.2
ENST00000423581.1 |
AP000476.1
|
AP000476.1 |
| chr6_+_43603552 | 1.37 |
ENST00000372171.4
|
MAD2L1BP
|
MAD2L1 binding protein |
| chr11_-_36619771 | 1.37 |
ENST00000311485.3
ENST00000527033.1 ENST00000532616.1 |
RAG2
|
recombination activating gene 2 |
| chr12_+_45609797 | 1.37 |
ENST00000425752.2
|
ANO6
|
anoctamin 6 |
| chr4_+_77870856 | 1.36 |
ENST00000264893.6
ENST00000502584.1 ENST00000510641.1 |
SEPT11
|
septin 11 |
| chr15_+_63414760 | 1.35 |
ENST00000557972.1
|
LACTB
|
lactamase, beta |
| chr19_-_56249740 | 1.35 |
ENST00000590200.1
ENST00000332836.2 |
NLRP9
|
NLR family, pyrin domain containing 9 |
| chr15_+_71389281 | 1.35 |
ENST00000355327.3
|
THSD4
|
thrombospondin, type I, domain containing 4 |
| chr7_-_23053719 | 1.34 |
ENST00000432176.2
ENST00000440481.1 |
FAM126A
|
family with sequence similarity 126, member A |
| chr6_+_31555045 | 1.34 |
ENST00000396101.3
ENST00000490742.1 |
LST1
|
leukocyte specific transcript 1 |
| chr2_+_65216462 | 1.34 |
ENST00000234256.3
|
SLC1A4
|
solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 |
| chr1_-_150780757 | 1.32 |
ENST00000271651.3
|
CTSK
|
cathepsin K |
| chrX_+_153448107 | 1.32 |
ENST00000369935.5
|
OPN1MW
|
opsin 1 (cone pigments), medium-wave-sensitive |
| chr20_-_48530230 | 1.31 |
ENST00000422556.1
|
SPATA2
|
spermatogenesis associated 2 |
| chr19_-_17958832 | 1.31 |
ENST00000458235.1
|
JAK3
|
Janus kinase 3 |
| chr10_+_90424196 | 1.31 |
ENST00000394375.3
ENST00000608620.1 ENST00000238983.4 ENST00000355843.2 |
LIPF
|
lipase, gastric |
| chr2_+_168043793 | 1.30 |
ENST00000409273.1
ENST00000409605.1 |
XIRP2
|
xin actin-binding repeat containing 2 |
| chr9_+_74920335 | 1.29 |
ENST00000451596.2
ENST00000436054.1 |
RP11-63P12.6
|
RP11-63P12.6 |
| chr1_-_203055129 | 1.29 |
ENST00000241651.4
|
MYOG
|
myogenin (myogenic factor 4) |
| chr2_+_75061108 | 1.29 |
ENST00000290573.2
|
HK2
|
hexokinase 2 |
| chr8_+_38585704 | 1.28 |
ENST00000519416.1
ENST00000520615.1 |
TACC1
|
transforming, acidic coiled-coil containing protein 1 |
| chr12_+_20968608 | 1.28 |
ENST00000381541.3
ENST00000540229.1 ENST00000553473.1 ENST00000554957.1 |
LST3
SLCO1B3
SLCO1B7
|
Putative solute carrier organic anion transporter family member 1B7; Uncharacterized protein solute carrier organic anion transporter family, member 1B3 solute carrier organic anion transporter family, member 1B7 (non-functional) |
| chr5_+_135385202 | 1.27 |
ENST00000514554.1
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa |
| chr2_-_74753332 | 1.27 |
ENST00000451518.1
ENST00000404568.3 |
DQX1
|
DEAQ box RNA-dependent ATPase 1 |
| chr16_+_30212378 | 1.27 |
ENST00000569485.1
|
SULT1A3
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3 |
| chr7_+_86274145 | 1.27 |
ENST00000439827.1
ENST00000394720.2 ENST00000421579.1 |
GRM3
|
glutamate receptor, metabotropic 3 |
| chr2_-_74753305 | 1.27 |
ENST00000393951.2
|
DQX1
|
DEAQ box RNA-dependent ATPase 1 |
| chr2_-_235405168 | 1.26 |
ENST00000339728.3
|
ARL4C
|
ADP-ribosylation factor-like 4C |
| chr6_+_31554636 | 1.26 |
ENST00000433492.1
|
LST1
|
leukocyte specific transcript 1 |
| chrX_+_15767971 | 1.26 |
ENST00000479740.1
ENST00000454127.2 |
CA5B
|
carbonic anhydrase VB, mitochondrial |
| chr5_+_66124590 | 1.25 |
ENST00000490016.2
ENST00000403666.1 ENST00000450827.1 |
MAST4
|
microtubule associated serine/threonine kinase family member 4 |
| chr18_+_72167096 | 1.25 |
ENST00000324301.8
|
CNDP2
|
CNDP dipeptidase 2 (metallopeptidase M20 family) |
| chr6_+_10585979 | 1.25 |
ENST00000265012.4
|
GCNT2
|
glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group) |
| chr20_-_43729750 | 1.25 |
ENST00000537075.1
ENST00000306117.1 |
KCNS1
|
potassium voltage-gated channel, delayed-rectifier, subfamily S, member 1 |
| chrX_+_18725758 | 1.25 |
ENST00000472826.1
ENST00000544635.1 ENST00000496075.2 |
PPEF1
|
protein phosphatase, EF-hand calcium binding domain 1 |
| chr2_-_231084820 | 1.25 |
ENST00000258382.5
ENST00000338556.3 |
SP110
|
SP110 nuclear body protein |
| chr11_-_76381029 | 1.24 |
ENST00000407242.2
ENST00000421973.1 |
LRRC32
|
leucine rich repeat containing 32 |
| chr9_+_74920408 | 1.24 |
ENST00000451152.1
|
RP11-63P12.6
|
RP11-63P12.6 |
| chr6_-_43496605 | 1.24 |
ENST00000455285.2
|
XPO5
|
exportin 5 |
| chr17_+_7341586 | 1.24 |
ENST00000575235.1
|
FGF11
|
fibroblast growth factor 11 |
| chr13_+_49551020 | 1.23 |
ENST00000541916.1
|
FNDC3A
|
fibronectin type III domain containing 3A |
| chr4_+_95917383 | 1.22 |
ENST00000512312.1
|
BMPR1B
|
bone morphogenetic protein receptor, type IB |
| chr13_-_46716969 | 1.22 |
ENST00000435666.2
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin) |
| chr4_+_70146217 | 1.22 |
ENST00000335568.5
ENST00000511240.1 |
UGT2B28
|
UDP glucuronosyltransferase 2 family, polypeptide B28 |
| chr12_-_89919765 | 1.21 |
ENST00000541909.1
ENST00000313546.3 |
POC1B
|
POC1 centriolar protein B |
| chr16_+_29472707 | 1.21 |
ENST00000565290.1
|
SULT1A4
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4 |
| chr1_+_101003687 | 1.21 |
ENST00000315033.4
|
GPR88
|
G protein-coupled receptor 88 |
| chr16_-_87970122 | 1.18 |
ENST00000309893.2
|
CA5A
|
carbonic anhydrase VA, mitochondrial |
| chr22_+_36649056 | 1.18 |
ENST00000397278.3
ENST00000422706.1 ENST00000426053.1 ENST00000319136.4 |
APOL1
|
apolipoprotein L, 1 |
| chr19_+_18043810 | 1.18 |
ENST00000445755.2
|
CCDC124
|
coiled-coil domain containing 124 |
| chr9_-_132404374 | 1.17 |
ENST00000277459.4
ENST00000450050.2 ENST00000277458.4 |
ASB6
|
ankyrin repeat and SOCS box containing 6 |
| chr15_-_100273544 | 1.17 |
ENST00000409796.1
ENST00000545021.1 ENST00000344791.2 ENST00000332728.4 ENST00000450512.1 |
LYSMD4
|
LysM, putative peptidoglycan-binding, domain containing 4 |
| chr18_+_56806701 | 1.16 |
ENST00000587834.1
|
SEC11C
|
SEC11 homolog C (S. cerevisiae) |
| chr11_-_119993979 | 1.16 |
ENST00000524816.3
ENST00000525327.1 |
TRIM29
|
tripartite motif containing 29 |
| chr19_+_11457232 | 1.16 |
ENST00000587531.1
|
CCDC159
|
coiled-coil domain containing 159 |
| chr6_+_30539153 | 1.16 |
ENST00000326195.8
ENST00000376545.3 ENST00000396515.4 ENST00000441867.1 ENST00000468958.1 |
ABCF1
|
ATP-binding cassette, sub-family F (GCN20), member 1 |
| chr7_+_134528635 | 1.16 |
ENST00000445569.2
|
CALD1
|
caldesmon 1 |
| chr10_-_121302195 | 1.15 |
ENST00000369103.2
|
RGS10
|
regulator of G-protein signaling 10 |
| chr2_-_136678123 | 1.15 |
ENST00000422708.1
|
DARS
|
aspartyl-tRNA synthetase |
Network of associatons between targets according to the STRING database.
First level regulatory network of RHOXF1
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.7 | 11.0 | GO:0046967 | cytosol to ER transport(GO:0046967) |
| 1.9 | 9.4 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
| 1.8 | 7.3 | GO:2000329 | negative regulation of T-helper 17 cell lineage commitment(GO:2000329) |
| 1.6 | 8.2 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) positive regulation of calcium:sodium antiporter activity(GO:1903281) positive regulation of potassium ion import(GO:1903288) |
| 1.5 | 5.8 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 1.4 | 4.2 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 1.3 | 10.6 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 1.2 | 3.7 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 1.2 | 7.3 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
| 1.0 | 3.1 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
| 1.0 | 2.9 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
| 0.9 | 2.8 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 0.9 | 3.7 | GO:0009224 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.8 | 3.1 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
| 0.8 | 3.1 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
| 0.8 | 2.3 | GO:1902568 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 0.8 | 7.6 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 0.7 | 2.2 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
| 0.7 | 5.5 | GO:0030578 | PML body organization(GO:0030578) |
| 0.6 | 2.6 | GO:0044501 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.6 | 2.3 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
| 0.6 | 2.2 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
| 0.5 | 2.0 | GO:0061743 | motor learning(GO:0061743) |
| 0.5 | 3.0 | GO:0030035 | microspike assembly(GO:0030035) |
| 0.5 | 1.9 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
| 0.5 | 1.9 | GO:0001545 | primary ovarian follicle growth(GO:0001545) |
| 0.4 | 1.8 | GO:1900245 | negative regulation of MDA-5 signaling pathway(GO:0039534) positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.4 | 4.0 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 0.4 | 1.3 | GO:0002731 | negative regulation of dendritic cell cytokine production(GO:0002731) FasL biosynthetic process(GO:0045210) |
| 0.4 | 0.4 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
| 0.4 | 1.2 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
| 0.4 | 0.4 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
| 0.4 | 1.6 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
| 0.4 | 1.2 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.4 | 1.5 | GO:0010816 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.4 | 2.2 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.4 | 1.4 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
| 0.4 | 1.4 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
| 0.4 | 4.6 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
| 0.4 | 1.1 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.3 | 1.4 | GO:0097045 | phosphatidylserine exposure on blood platelet(GO:0097045) |
| 0.3 | 1.0 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.3 | 0.7 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.3 | 1.0 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.3 | 1.9 | GO:0015808 | L-alanine transport(GO:0015808) |
| 0.3 | 1.0 | GO:0007518 | myoblast fate determination(GO:0007518) |
| 0.3 | 0.3 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.3 | 0.9 | GO:1901896 | left ventricular cardiac muscle tissue morphogenesis(GO:0003220) positive regulation of calcium-transporting ATPase activity(GO:1901896) |
| 0.3 | 0.9 | GO:0002352 | B cell negative selection(GO:0002352) post-embryonic camera-type eye morphogenesis(GO:0048597) |
| 0.3 | 1.2 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
| 0.3 | 1.2 | GO:0060133 | somatotropin secreting cell development(GO:0060133) |
| 0.3 | 0.9 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.3 | 2.4 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.3 | 3.3 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.3 | 1.5 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
| 0.3 | 1.4 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 0.3 | 1.9 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
| 0.3 | 1.6 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.3 | 1.1 | GO:0072658 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.3 | 1.9 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
| 0.3 | 1.9 | GO:0003383 | apical constriction(GO:0003383) |
| 0.3 | 0.8 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
| 0.3 | 1.3 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
| 0.3 | 0.8 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
| 0.3 | 1.0 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 0.3 | 0.3 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
| 0.2 | 0.7 | GO:0097254 | renal tubular secretion(GO:0097254) |
| 0.2 | 1.2 | GO:0048165 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.2 | 1.2 | GO:1902162 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.2 | 2.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.2 | 0.7 | GO:0034471 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 0.2 | 1.4 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.2 | 1.6 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
| 0.2 | 0.7 | GO:0033023 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
| 0.2 | 0.9 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) regulation of cyclic nucleotide-gated ion channel activity(GO:1902159) |
| 0.2 | 3.0 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.2 | 1.3 | GO:1904925 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 0.2 | 0.8 | GO:1905176 | metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) positive regulation of phenotypic switching(GO:1900241) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
| 0.2 | 2.5 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
| 0.2 | 1.7 | GO:0051177 | meiotic sister chromatid cohesion(GO:0051177) |
| 0.2 | 0.6 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.2 | 0.6 | GO:0015785 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
| 0.2 | 1.0 | GO:0072143 | mesangial cell development(GO:0072143) |
| 0.2 | 0.8 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
| 0.2 | 3.7 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.2 | 0.8 | GO:0035963 | cellular response to interleukin-13(GO:0035963) |
| 0.2 | 0.8 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 0.2 | 1.5 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
| 0.2 | 1.1 | GO:1903286 | regulation of potassium ion import(GO:1903286) |
| 0.2 | 0.6 | GO:1904106 | protein localization to microvillus(GO:1904106) |
| 0.2 | 1.1 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.2 | 5.2 | GO:0008053 | mitochondrial fusion(GO:0008053) |
| 0.2 | 1.3 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.2 | 0.7 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.2 | 1.0 | GO:0071104 | response to interleukin-9(GO:0071104) response to interleukin-11(GO:0071105) |
| 0.2 | 0.5 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
| 0.2 | 0.5 | GO:1900368 | regulation of RNA interference(GO:1900368) |
| 0.2 | 1.4 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.2 | 0.5 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
| 0.2 | 5.2 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.2 | 0.7 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.2 | 1.3 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.2 | 1.2 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
| 0.2 | 1.6 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.2 | 0.3 | GO:0010650 | positive regulation of cell communication by electrical coupling(GO:0010650) |
| 0.2 | 3.7 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.2 | 1.1 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.2 | 1.0 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
| 0.2 | 3.2 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
| 0.2 | 1.2 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
| 0.2 | 0.9 | GO:0035995 | detection of muscle stretch(GO:0035995) |
| 0.2 | 0.3 | GO:0002740 | negative regulation of cytokine secretion involved in immune response(GO:0002740) |
| 0.1 | 0.9 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.1 | 1.6 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
| 0.1 | 1.9 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.1 | 0.7 | GO:0048749 | compound eye development(GO:0048749) |
| 0.1 | 0.6 | GO:0016559 | peroxisome fission(GO:0016559) |
| 0.1 | 4.3 | GO:0010447 | response to acidic pH(GO:0010447) |
| 0.1 | 0.9 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 0.1 | 0.9 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
| 0.1 | 0.4 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.1 | 0.7 | GO:0009804 | coumarin metabolic process(GO:0009804) |
| 0.1 | 0.1 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
| 0.1 | 0.4 | GO:0032906 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
| 0.1 | 1.9 | GO:0001553 | luteinization(GO:0001553) |
| 0.1 | 0.4 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.1 | 0.4 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
| 0.1 | 0.5 | GO:2000437 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
| 0.1 | 0.8 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.1 | 0.4 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
| 0.1 | 0.5 | GO:0035803 | egg coat formation(GO:0035803) |
| 0.1 | 0.4 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.1 | 0.8 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
| 0.1 | 0.4 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 0.1 | 0.4 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
| 0.1 | 0.9 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.1 | 0.6 | GO:0043091 | L-arginine import(GO:0043091) arginine import(GO:0090467) |
| 0.1 | 0.5 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.1 | 0.6 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.1 | 0.9 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.1 | 0.7 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
| 0.1 | 0.4 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
| 0.1 | 0.9 | GO:0016078 | tRNA catabolic process(GO:0016078) |
| 0.1 | 0.7 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.1 | 0.4 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
| 0.1 | 0.4 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.1 | 0.4 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
| 0.1 | 0.5 | GO:0036269 | swimming behavior(GO:0036269) |
| 0.1 | 0.7 | GO:0048241 | epinephrine transport(GO:0048241) |
| 0.1 | 0.4 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
| 0.1 | 0.6 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 0.1 | 0.4 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
| 0.1 | 0.4 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
| 0.1 | 1.2 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.1 | 0.7 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
| 0.1 | 0.6 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.1 | 1.0 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
| 0.1 | 11.5 | GO:0050672 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
| 0.1 | 0.5 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 0.1 | 0.7 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.1 | 0.3 | GO:0034475 | U4 snRNA 3'-end processing(GO:0034475) polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.1 | 0.9 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.1 | 0.8 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.1 | 2.3 | GO:0052695 | cellular glucuronidation(GO:0052695) |
| 0.1 | 0.1 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
| 0.1 | 0.9 | GO:0015705 | iodide transport(GO:0015705) |
| 0.1 | 1.6 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.1 | 0.3 | GO:1903978 | negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) regulation of microglial cell activation(GO:1903978) |
| 0.1 | 0.2 | GO:0043103 | hypoxanthine salvage(GO:0043103) |
| 0.1 | 0.6 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
| 0.1 | 0.6 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.1 | 0.5 | GO:0046108 | uridine metabolic process(GO:0046108) |
| 0.1 | 9.5 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
| 0.1 | 1.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.1 | 0.4 | GO:0090034 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 0.1 | 2.3 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.1 | 0.3 | GO:1900158 | hormone-mediated apoptotic signaling pathway(GO:0008628) positive regulation of osteoclast proliferation(GO:0090290) negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
| 0.1 | 1.6 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.1 | 0.2 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
| 0.1 | 0.3 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
| 0.1 | 0.6 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
| 0.1 | 0.5 | GO:0072233 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
| 0.1 | 0.6 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
| 0.1 | 0.3 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
| 0.1 | 1.1 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
| 0.1 | 0.6 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.1 | 0.6 | GO:0046477 | glycoside catabolic process(GO:0016139) glycosylceramide catabolic process(GO:0046477) |
| 0.1 | 1.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.1 | 0.3 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.1 | 1.3 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 0.1 | 0.7 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
| 0.1 | 1.3 | GO:0006108 | malate metabolic process(GO:0006108) |
| 0.1 | 0.6 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.1 | 0.7 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.1 | 1.2 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.1 | 0.6 | GO:2000771 | regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
| 0.1 | 0.7 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.1 | 0.2 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
| 0.1 | 0.6 | GO:0048664 | neuron fate determination(GO:0048664) |
| 0.1 | 0.5 | GO:0015746 | tricarboxylic acid transport(GO:0006842) succinate transport(GO:0015744) citrate transport(GO:0015746) succinate transmembrane transport(GO:0071422) |
| 0.1 | 8.0 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
| 0.1 | 0.4 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 0.1 | 0.5 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.1 | 1.7 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
| 0.1 | 0.6 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
| 0.1 | 0.7 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
| 0.1 | 0.6 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.1 | 0.3 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.1 | 0.3 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.1 | 1.1 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.1 | 0.4 | GO:0030581 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.1 | 0.5 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
| 0.1 | 0.8 | GO:0097267 | omega-hydroxylase P450 pathway(GO:0097267) |
| 0.1 | 1.1 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 0.1 | 1.2 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.1 | 0.2 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
| 0.1 | 0.2 | GO:1900110 | negative regulation of histone H3-K9 dimethylation(GO:1900110) regulation of TORC2 signaling(GO:1903939) |
| 0.1 | 0.3 | GO:0044026 | DNA hypermethylation(GO:0044026) |
| 0.1 | 1.1 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 0.1 | 0.6 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 0.1 | 0.9 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 0.1 | 0.6 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.1 | 0.3 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 0.1 | 0.6 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.1 | 0.3 | GO:0032972 | diaphragm contraction(GO:0002086) regulation of muscle filament sliding speed(GO:0032972) |
| 0.1 | 0.1 | GO:1901094 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 0.1 | 0.7 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 0.1 | 0.2 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
| 0.1 | 0.6 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 0.1 | 0.2 | GO:0007440 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
| 0.1 | 0.4 | GO:0043305 | negative regulation of mast cell degranulation(GO:0043305) |
| 0.1 | 0.4 | GO:0048023 | regulation of melanin biosynthetic process(GO:0048021) positive regulation of melanin biosynthetic process(GO:0048023) regulation of secondary metabolite biosynthetic process(GO:1900376) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
| 0.1 | 0.4 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 0.1 | 2.3 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
| 0.1 | 2.8 | GO:0016486 | peptide hormone processing(GO:0016486) |
| 0.1 | 3.2 | GO:0000266 | mitochondrial fission(GO:0000266) |
| 0.1 | 1.5 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.1 | 0.7 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.1 | 0.3 | GO:0071231 | cellular response to folic acid(GO:0071231) |
| 0.1 | 0.4 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 0.1 | 0.4 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.1 | 0.3 | GO:1902361 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 0.1 | 0.6 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
| 0.1 | 0.4 | GO:0071494 | cellular response to UV-C(GO:0071494) |
| 0.1 | 0.3 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.1 | 0.6 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
| 0.1 | 0.4 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.1 | 1.0 | GO:0090399 | replicative senescence(GO:0090399) |
| 0.1 | 0.3 | GO:1902613 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 0.1 | 0.2 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.1 | 0.9 | GO:0019532 | oxalate transport(GO:0019532) |
| 0.1 | 1.6 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.1 | 0.5 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
| 0.1 | 7.7 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
| 0.1 | 5.2 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.1 | 0.3 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
| 0.1 | 0.4 | GO:1902957 | negative regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902957) |
| 0.1 | 0.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 0.1 | 0.1 | GO:0032900 | regulation of nucleoside transport(GO:0032242) negative regulation of neurotrophin production(GO:0032900) negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 0.1 | 0.5 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
| 0.1 | 0.6 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.1 | 0.9 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.1 | 0.5 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.1 | 1.4 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
| 0.1 | 0.5 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 0.1 | 0.2 | GO:0048075 | positive regulation of eye pigmentation(GO:0048075) |
| 0.1 | 1.7 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
| 0.1 | 0.4 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.1 | 0.5 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.1 | 0.5 | GO:0009441 | glycolate metabolic process(GO:0009441) |
| 0.1 | 0.3 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 0.1 | 0.7 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 0.1 | 0.2 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
| 0.1 | 1.0 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.1 | 0.4 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.1 | 1.0 | GO:0060134 | prepulse inhibition(GO:0060134) |
| 0.1 | 2.9 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.1 | 0.2 | GO:2000653 | negative regulation of DNA demethylation(GO:1901536) regulation of genetic imprinting(GO:2000653) |
| 0.1 | 0.3 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.1 | 0.4 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
| 0.1 | 0.7 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.1 | 0.6 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
| 0.1 | 0.6 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
| 0.1 | 0.2 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
| 0.1 | 0.8 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 0.1 | 0.5 | GO:1990403 | embryonic brain development(GO:1990403) |
| 0.1 | 1.6 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.0 | 0.8 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
| 0.0 | 0.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.0 | 0.1 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
| 0.0 | 0.2 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
| 0.0 | 0.1 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 0.0 | 2.6 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.0 | 0.2 | GO:0034227 | tRNA thio-modification(GO:0034227) |
| 0.0 | 7.4 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
| 0.0 | 0.8 | GO:0070987 | error-free translesion synthesis(GO:0070987) |
| 0.0 | 0.5 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.0 | 0.5 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.0 | 0.7 | GO:0090220 | chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
| 0.0 | 0.3 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
| 0.0 | 0.1 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
| 0.0 | 0.8 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.0 | 0.7 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
| 0.0 | 0.2 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.0 | 0.4 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.0 | 0.3 | GO:0033504 | floor plate development(GO:0033504) |
| 0.0 | 0.2 | GO:0032571 | response to vitamin K(GO:0032571) |
| 0.0 | 0.4 | GO:0090292 | nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.0 | 0.3 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.0 | 0.3 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.0 | 0.3 | GO:0006983 | ER overload response(GO:0006983) |
| 0.0 | 0.2 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.0 | 0.2 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
| 0.0 | 0.7 | GO:0006828 | manganese ion transport(GO:0006828) |
| 0.0 | 0.8 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.0 | 0.2 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.0 | 0.0 | GO:0042640 | anagen(GO:0042640) hair cycle phase(GO:0044851) |
| 0.0 | 2.8 | GO:0010965 | regulation of mitotic sister chromatid separation(GO:0010965) |
| 0.0 | 0.1 | GO:0018874 | benzoate metabolic process(GO:0018874) |
| 0.0 | 0.2 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.0 | 0.1 | GO:0008272 | sulfate transport(GO:0008272) |
| 0.0 | 2.0 | GO:0043486 | histone exchange(GO:0043486) |
| 0.0 | 0.8 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
| 0.0 | 0.1 | GO:0015855 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 0.0 | 0.0 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.0 | 3.8 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.0 | 1.4 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
| 0.0 | 0.3 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
| 0.0 | 5.4 | GO:0045727 | positive regulation of translation(GO:0045727) |
| 0.0 | 0.9 | GO:0097186 | amelogenesis(GO:0097186) |
| 0.0 | 0.3 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
| 0.0 | 0.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.0 | 0.5 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.0 | 1.0 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.0 | 0.1 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.0 | 0.1 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 0.0 | 0.6 | GO:0002544 | chronic inflammatory response(GO:0002544) |
| 0.0 | 1.0 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
| 0.0 | 0.6 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.0 | 0.3 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.0 | 0.4 | GO:0010818 | T cell chemotaxis(GO:0010818) |
| 0.0 | 0.2 | GO:0042048 | olfactory behavior(GO:0042048) |
| 0.0 | 0.1 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
| 0.0 | 0.2 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.0 | 0.1 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.0 | 1.7 | GO:0042255 | ribosome assembly(GO:0042255) |
| 0.0 | 0.7 | GO:0060009 | Sertoli cell development(GO:0060009) |
| 0.0 | 0.3 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.0 | 0.2 | GO:0031268 | pseudopodium organization(GO:0031268) |
| 0.0 | 0.3 | GO:0060155 | platelet dense granule organization(GO:0060155) |
| 0.0 | 0.4 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.0 | 1.1 | GO:0051983 | regulation of chromosome segregation(GO:0051983) |
| 0.0 | 0.4 | GO:0043383 | negative T cell selection(GO:0043383) |
| 0.0 | 0.3 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.0 | 0.4 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
| 0.0 | 0.1 | GO:0030916 | otic vesicle formation(GO:0030916) |
| 0.0 | 0.9 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
| 0.0 | 1.2 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
| 0.0 | 0.5 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.0 | 1.4 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
| 0.0 | 1.0 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.0 | 1.1 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.0 | 1.4 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
| 0.0 | 0.1 | GO:1901162 | primary amino compound biosynthetic process(GO:1901162) |
| 0.0 | 2.9 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
| 0.0 | 0.4 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.0 | 0.3 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 0.0 | 0.0 | GO:1902306 | negative regulation of sodium ion transmembrane transport(GO:1902306) |
| 0.0 | 0.1 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
| 0.0 | 0.2 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.0 | 0.9 | GO:0048741 | skeletal muscle fiber development(GO:0048741) |
| 0.0 | 0.2 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
| 0.0 | 0.5 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.0 | 0.3 | GO:0050856 | regulation of T cell receptor signaling pathway(GO:0050856) |
| 0.0 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.0 | 2.5 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
| 0.0 | 0.3 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
| 0.0 | 1.5 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.0 | 0.6 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.0 | 0.2 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
| 0.0 | 0.2 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
| 0.0 | 0.1 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 0.0 | 0.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 | 1.5 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
| 0.0 | 1.9 | GO:0051781 | positive regulation of cell division(GO:0051781) |
| 0.0 | 0.8 | GO:0030488 | tRNA methylation(GO:0030488) |
| 0.0 | 0.1 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
| 0.0 |